.jpg&contenttype=jpeg)
Categories
Page 8 from 17
<<First <Previous Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 Next> Last>>
In-vivo and in-vitro diagnostics in molecular medicine
In molecular medicine – and particularly in oncology - Siemens Medical Solutions is concentrating on further development of the FDG (fluorodeoxyglucose) biomarker to improve Read more …
What’s your prediction for MR? ‘Expect the unexpected’
Since April, there’s been a new man at GE Healthcare´s global MRI division; its new Vice President and General Manager is James E Davis. Meike Lerner caught up with him Read more …
Molecular imaging and biomarkers
Whilst Siemens AG in Germany is going through turbulent times, the medical branch of the business remains on steady ground.
Read more …
A world-class radiotherapy service
United Kingdom – An independent report that suggests better ways to use the UK’s current radiotherapy resources, as well as predicting the needs of a radiotherapy service in the Read more …
Radiofrequency ablation in breast cancer
By Beate M Stoeckelhuber MD, Associate Professor and Radiology (Interim) Director at the Department of Radiology, Luebeck University, Germany, with Smaragda Kapsimalakou MD, also Read more …
World’s largest gathering of cancer specialists told: Mammography is still key to survival
Rapid diagnosis and treatment are the keys to breast cancer survival – and an elastogram mammography continues to play a central role in breast cancer detection according to Read more …
New technology to reduce biopsies
]Although about 75% of biopsies are negative, the side effects of that invasive procedure, plus the length of time to results, disturbs patients. Now, however, a new technology Read more …
Tissue elasticity reveals tumours
When equally compressed, the tissue and structure of tumours and inflammations are harder than normal tissue. Hitachi explains that, taking advantage of these alterations, the Read more …
Ireland Pulling into Europe’s fast lane for digital screening
In Ireland, breast cancer is particularly virulent: 18.5% of all cancer related deaths among the women are due to breast cancer.
Read more …
3D USCT nears reality
Back in the 70s, when scientists first speculated on the development of 3-D ultrasound computed tomography (3-D USCT) the available technology could not equal their dreams. Now, Read more …
Hospital group streamlines screening
Italy – One of the biggest RIS/PACS implementations in Europe is being co-ordinated the Area Vasta Centro (AVC) group, which runs 12 hospitals in central Tuscany. Among these, CPA Read more …
Why MRI should not be a health-political decision
During the recent American Society of Clinical Oncology (ASCO) congress, the paper of Professor Christiane K Kuhl* and her colleagues has been selected as ‘Best of ASCO’ , for Read more …
Buzz words: digital mammography
Full field digital mammography (FFDM) and computed radiography (CR) based mammography systems may bring hospitals and breast imaging services closer to gaining digital Read more …
CTLM for cancer detection in dense breasts
Paolo Belli MD, Carmen Malaspina MD and Professor Lorenzo Bonomo, of the Department of Radiology, UCSC, Policlinico A. Gemelli, Rome, discuss results from using computed Read more …
Greater bonding of radiation oncologists and diagnostic radiologists sought by RSNA
Radiation oncologists and diagnostic radiologists will be encouraged to forge partnerships at the Radiological Society of North America (RSNA) congress in Chicago this November Read more …
Revealing the breast’s architecture
2D imaging - whether analogue or digital - is thought to miss detection of 20-30% of breast cancers. Early clinical results from studies using the new technology tomosynthesis Read more …
Tomorrow’s imaging on today’s horizon
‘Tomosynthesis is a hot topic in all the companies involved in mammography’, Professor Danielsson pointed out. ‘But whereas they are developing more or less the same thing, Sectra Read more …
Germany’s early detection programme and research
In 2002, Germany implemented an early detection programme for breast cancer. The digital Reference Centre For Mammography at the University Hospital Münster is one of five Read more …
Testing time for tomosynthesis
What next? A combination of ultrasound and tomosynthesis?
By Dr Ingvar Andersson
Read more …
Digital breast tomosynthesis
By Thomas Mertelmeier, Principal Scientist at Siemens AG Medical Solutions Read more …
European Commission is open for amendment of the directive on the use of MRI
After a new study published by Professor Stuart Crozier has shown that the use of MR in the clinical practice will not be possible when realizing the EU Physical Agents Directive Read more …
<<First <Previous Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 Next> Last>>
